IREN
IREN Limited
There isn't enough reported data to score IREN yet.
SCHW
The Charles Schwab Corporation
SCHW's fundamentals are strong and it looks cheap: trading at 16x earnings, below its usual 24x. Analysts expect strong earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
SCHW Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
SCHW's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like SCHW.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
SCHW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $91.72 | — |
| Cheap | 16x | $95.94 | +4.6% |
| Current | 16x | $91.72 | — |
| Fair | 24x | $140 | +52% |
| Expensive | 30x | $178 | +94% |
Historical ranges are pointers, not guarantees.
SCHW's PE is in its cheap range at 16x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
SCHW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| High |
SCHW has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
SCHW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.48 | +28% |
| Q3 2026 | $5.85 | +37% |
| Q2 2026 | $5.49 | +48% |
| Q1 2026 | $5.03 | +52% |
| Q4 2025 | $4.65 | +56% |
| Q3 2025 | $4.27 | +67% |
| Q2 2025 | $3.72 | +54% |
| Q1 2025 | $3.30 | +38% |
| Q4 2024 | $2.99 | +18% |
SCHW has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
SCHW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.2B | +17% |
| Q2 2026 | $7.1B | +21% |
| Q1 2026 | $6.5B | +16% |
| Q4 2025 | $6.3B | +19% |
| Q3 2025 | $6.1B | +27% |
| Q2 2025 | $5.9B | +25% |
| Q1 2025 | $5.6B | +18% |
| Q4 2024 | $5.3B | +20% |
SCHW's revenue has grown year over year for 10 quarters in a row: $7.2B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 53% | +3.4 points |
| Q2 2026 | 52% | +4 points |
| Q1 2026 | 49% | +5.3 points |
| Q4 2025 | 50% | +6.9 points |
| Q3 2025 | 49% | +11 points |
| Q2 2025 | 48% | +11 points |
| Q1 2025 | 44% | +5.9 points |
| Q4 2024 | 43% | +17 points |
SCHW has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
SCHW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +231% |
| Q2 2026 | $4.1B | +35% |
| Q1 2026 | $7.2B | +15% |
| Q4 2025 | -$921M | +$10.2B |
| Q3 2025 | $393M | -98% |
| Q2 2025 | $3B | +$7.4B |
| Q1 2025 | $6.2B | +$7.7B |
| Q4 2024 | -$11.1B | -155% |
SCHW has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
SCHW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -6M shares |
| 1 year | -4.3% | -78M shares |
| 3 years | -5.1% | -94M shares |
| 5 years | -8.7% | -165M shares |
| Available history | +34% | +440M shares |
SCHW has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $500M |
| Q2 2026 | $999M |
| Q1 2026 | $2.4B |
| Q1 2025 | $1.5B |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
SCHW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2020 | -5.4x | Net Cash |
| Q1 2020 | -12.0x | Net Cash |
| Q4 2019 | -4.2x | Net Cash |
SCHW has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like SCHW.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
SCHW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.9 | Neutral |
| Stochastic | 11.2 | Oversold |
SCHW's weekly RSI is 41 (neutral) and its Stochastic is 11 (oversold).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
SCHW PE vs Financial Services Sector
| Metric | SCHW | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 20% above |
| PE % | 14 | 63 | 49 pts below |
SCHW is trading at 16x earnings, a 20% premium to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
SCHW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $93.3 | 1.7% below |
| 20 week MA | $100.9 | 9.1% below |
| 50 week MA | $97.3 | 5.7% below |
| 100 week MA | $92.0 | 0.3% below |
| 200 week MA | $78.5 | 17% above |
SCHW has fallen below most of its moving averages, though it's still 17% above its 200-week average.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
SCHW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.3 | $52.1 | +7.7% |
| 2021 | $52.1 | $85.1 | +64% |
| 2022 | $85.1 | $81.8 | -3.9% |
| 2023 | $81.8 | $68.8 | -16% |
| 2024 | $68.8 | $74.7 | +8.6% |
| 2025 | $74.7 | $101.9 | +36% |
| 2026 YTD | $101.9 | $91.7 | -10% |
SCHW has the edge over IREN on returns for 2026, with the stronger performance.